Unravelling the reversibility of pulmonary vascular disease in HFpEF, aortic stenosis and CTEPH after intervention: the REVERS-PVD study (Trial Not Registered)
REVERS-PVD
This trial is Currently recruiting
Registration number Trial Not Registered
Program & service
This trial is being run with the Heart & Lung service, and as part of the Cardiology program.
Trial phase
Other
Trial participation type
This trial is for clinical research of something other than a drug or device.
Principal investigator
Professor David Kaye
If you would like further details or have any questions about this clinical trial, we encourage you to get in touch with us and a member of our team will be happy to provide you with more information.